[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWu GC +5 more
europepmc +1 more source
[Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLu XL +5 more
europepmc +1 more source
[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang J, Zhan RX, Wang Y, Nan YM.
europepmc +1 more source
[Advances in basic and experimental diagnostic research on liver diseases in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiChen DB, Yang RF, Chen HS.
europepmc +1 more source
[Excerpt from the 2025 EASL practice guidelines for the diagnosis and treatment of extrahepatic cholangiocarcinoma]. [PDF]
Zhonghua Gan Zang Bing Za ZhiShang YW, Han GH.
europepmc +1 more source
[Role of glutathione in regulating ferroptosis and cuproptosis in metabolic dysfunction-associated steatotic liver disease]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanLiu S, Long Y, Yang L.
europepmc +1 more source
[An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLuo BH, Han GH.
europepmc +1 more source
[Research advances on hepatocyte zonal changes in metabolic associated fatty liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi Y, Huang ZW, Gan JT, Zhang QF, Fu WW.
europepmc +1 more source
[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiFatty Liver and Alcoholic Liver Disease Study Group +2 more
europepmc +1 more source